Literature DB >> 16979699

Laparoscopic partial adrenalectomy for aldosterone-producing adenomas with needlescopic instruments.

Chun-Hou Liao1, Shih-Chieh Chueh, Kwan-Dun Wu, Ming-Hsueh Hsieh, Jun Chen.   

Abstract

INTRODUCTION: Laparoscopic total adrenalectomy is the treatment of choice for aldosterone-producing adenomas (APAs). There have not been many reports of laparoscopic partial adrenalectomy, although this procedure offers benefits to patients with suspected bilateral APAs or an APA in a solitary adrenal gland. We describe the feasibility of a novel technique of laparoscopic partial adrenalectomy for APA solely using 2-mm working instruments and a 5 to 10-mm telescope. TECHNICAL CONSIDERATIONS: Six unilateral and two bilateral partial adrenalectomies were performed laparoscopically. Only one umbilical 12-mm port for the telescope and two (for left adenomas) or three (for right adenomas) subcostal 2-mm working ports were used. Hemostasis and transection of adrenal tissues were performed using a 2-mm mini-bipolar coagulator and 2-mm scissors.
RESULTS: All laparoscopic operations were successfully performed using only 2-mm working instruments and a 5 or 10-mm 30 degree telescope with no intraoperative or postoperative complications. Blood loss was minimal, and the operative times were comparable to those of previous reports. All patients had low pain scores, required minimal amounts of narcotics postoperatively, and reported excellent cosmetic results for the wounds. The pathologic examinations confirmed complete excision of all adenomas with intact capsules. The plasma aldosterone concentrations and renin activities returned to normal ranges postoperatively in all patients. At a mean follow-up of 25 months (range 13 to 48), 7 (87.5%) were cured of their hypertension and 1 had the hypertensive medications significantly reduced.
CONCLUSIONS: Laparoscopic partial adrenalectomy for APAs using 2-mm working instruments and a 5 to 10-mm telescope is a safe and effective treatment alternative.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16979699     DOI: 10.1016/j.urology.2006.04.036

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  7 in total

1.  Re: Outcome of surgery for primary hyperaldosternonism.

Authors:  Chun-Hou Liao; VinCent Wu; S Jeff Chueh; Bashir R Sankari
Journal:  World J Surg       Date:  2012-05       Impact factor: 3.352

2.  Single incision laparoscopic sleeve gastrectomy (SILS): a novel technique.

Authors:  Alan A Saber; Mohamed H Elgamal; Ed A Itawi; Arun J Rao
Journal:  Obes Surg       Date:  2008-08-08       Impact factor: 4.129

Review 3.  Adrenal-preserving minimally invasive surgery: update on the current status of laparoscopic partial adrenalectomy.

Authors:  Grant I S Disick; Ravi Munver
Journal:  Curr Urol Rep       Date:  2008-01       Impact factor: 3.092

4.  Robot-assisted laparoscopic partial adrenalectomy: initial experience.

Authors:  Ronald S Boris; Gopal Gupta; W Marston Linehan; Peter A Pinto; Gennady Bratslavsky
Journal:  Urology       Date:  2010-12-03       Impact factor: 2.649

Review 5.  Partial adrenalectomy: underused first line therapy for small adrenal tumors.

Authors:  Deborah R Kaye; Benjamin B Storey; Karel Pacak; Peter A Pinto; W Marston Linehan; Gennady Bratslavsky
Journal:  J Urol       Date:  2010-07       Impact factor: 7.450

6.  Robot-assisted laparoscopic partial adrenalectomy for pheochromocytoma: the National Cancer Institute technique.

Authors:  Kevin P Asher; Gopal N Gupta; Ronald S Boris; Peter A Pinto; W Marston Linehan; Gennady Bratslavsky
Journal:  Eur Urol       Date:  2011-04-09       Impact factor: 20.096

7.  Initial experience of transumbilical laparoendoscopic single-site surgery of partial adrenalectomy in patient with aldosterone-producing adenoma.

Authors:  Kazuyuki Yuge; Akira Miyajima; Masanori Hasegawa; Yasumasa Miyazaki; Takahiro Maeda; Toshikazu Takeda; Ayano Takeda; Kazutoshi Miyashita; Isao Kurihara; Hirotaka Shibata; Eiji Kikuchi; Mototsugu Oya
Journal:  BMC Urol       Date:  2010-11-23       Impact factor: 2.264

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.